Fear and confusion over abortion access persists as SCOTUS takes its first post-Dobbs case
The U.S. Supreme Court accepted a case last week challenging the FDA's 20-year approval of the abortion drug mifepristone. Fear and confusion persist among abortion rights advocates as the court is poised to make another major decision in 2024.